0 472

Cited 0 times in

Cited 0 times in

A phase II study to evaluate the efficacy of regorafenib in C-KIT mutated metastatic malignant melanoma patients who have progressed on first-line treatment: A Multicenter Trial of Korean Cancer Study Group (UN-14–13)

DC Field Value Language
dc.contributor.authorKim, K. H.-
dc.contributor.authorLee, H.J.-
dc.contributor.authorLee, S.J.-
dc.contributor.authorKim, M.-
dc.contributor.authorAhn, M.S.-
dc.contributor.authorChoi, M.Y.-
dc.contributor.authorLee, N.R.-
dc.contributor.authorJung, M.-
dc.contributor.authorShin, S. J.-
dc.date.accessioned2023-04-07T01:17:19Z-
dc.date.available2023-04-07T01:17:19Z-
dc.date.created2023-06-12-
dc.date.issued2022-10-
dc.identifier.issn0959-8049-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/193863-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherElsevier Science Ltd-
dc.relation.isPartOfEuropean Journal of Cancer-
dc.relation.isPartOfEUROPEAN JOURNAL OF CANCER-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleA phase II study to evaluate the efficacy of regorafenib in C-KIT mutated metastatic malignant melanoma patients who have progressed on first-line treatment: A Multicenter Trial of Korean Cancer Study Group (UN-14–13)-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorKim, K. H.-
dc.contributor.googleauthorLee, H.J.-
dc.contributor.googleauthorLee, S.J.-
dc.contributor.googleauthorKim, M.-
dc.contributor.googleauthorAhn, M.S.-
dc.contributor.googleauthorChoi, M.Y.-
dc.contributor.googleauthorLee, N.R.-
dc.contributor.googleauthorJung, M.-
dc.contributor.googleauthorShin, S. J.-
dc.identifier.doi10.1016/S0959-8049(22)01025-5-
dc.relation.journalcodeJ00809-
dc.identifier.eissn1879-0852-
dc.contributor.alternativeNameShin, Sang Joon-
dc.contributor.affiliatedAuthorKim, K. H.-
dc.contributor.affiliatedAuthorShin, S. J.-
dc.identifier.scopusid2-s2.0-85144017787-
dc.identifier.wosid000876973400216-
dc.citation.volume174-
dc.citation.numberSupppl 1-
dc.citation.startPageS85-
dc.citation.endPageS86-
dc.identifier.bibliographicCitationEuropean Journal of Cancer, Vol.174(Supppl 1) : S85-S86, 2022-10-
dc.identifier.rimsid79565-
dc.type.rimsART-
dc.description.journalClass1-
dc.description.journalClass1-
dc.type.docTypeArticle-
dc.description.isOpenAccessY-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
Appears in Collections:
7. Others (기타) > Others (기타) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.